These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 33233962)

  • 1. Quantitative Whole-Body Imaging of I-124-Labeled Adeno-Associated Viral Vector Biodistribution in Nonhuman Primates.
    Ballon DJ; Rosenberg JB; Fung EK; Nikolopoulou A; Kothari P; De BP; He B; Chen A; Heier LA; Sondhi D; Kaminsky SM; Mozley PD; Babich JW; Crystal RG
    Hum Gene Ther; 2020 Dec; 31(23-24):1237-1259. PubMed ID: 33233962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron Emission Tomography Quantitative Assessment of Off-Target Whole-Body Biodistribution of I-124-Labeled Adeno-Associated Virus Capsids Administered to Cerebral Spinal Fluid.
    Rosenberg JB; Fung EK; Dyke JP; De BP; Lou H; Kelly JM; Reejhsinghani L; Ricart Arbona RJ; Sondhi D; Kaminsky SM; Cartier N; Hinderer C; Hordeaux J; Wilson JM; Ballon DJ; Crystal RG
    Hum Gene Ther; 2023 Nov; 34(21-22):1095-1106. PubMed ID: 37624734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo selection in non-human primates identifies AAV capsids for on-target CSF delivery to spinal cord.
    Hanlon KS; Cheng M; Ferrer RM; Ryu JR; Lee B; De La Cruz D; Patel N; Espinoza P; Santoscoy MC; Gong Y; Ng C; Nguyen DM; Nammour J; Clark SW; Heine VM; Sun W; Kozarsky K; Maguire CA
    Mol Ther; 2024 Jun; ():. PubMed ID: 38845196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brain.
    Matsuzaki Y; Konno A; Mochizuki R; Shinohara Y; Nitta K; Okada Y; Hirai H
    Neurosci Lett; 2018 Feb; 665():182-188. PubMed ID: 29175632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioiodinated Capsids Facilitate In Vivo Non-Invasive Tracking of Adeno-Associated Gene Transfer Vectors.
    Kothari P; De BP; He B; Chen A; Chiuchiolo MJ; Kim D; Nikolopoulou A; Amor-Coarasa A; Dyke JP; Voss HU; Kaminsky SM; Foley CP; Vallabhajosula S; Hu B; DiMagno SG; Sondhi D; Crystal RG; Babich JW; Ballon D
    Sci Rep; 2017 Jan; 7():39594. PubMed ID: 28059103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive study of a 29-capsid AAV library in a non-human primate central nervous system.
    Kondratov O; Kondratova L; Mandel RJ; Coleman K; Savage MA; Gray-Edwards HL; Ness TJ; Rodriguez-Lebron E; Bell RD; Rabinowitz J; Gamlin PD; Zolotukhin S
    Mol Ther; 2021 Sep; 29(9):2806-2820. PubMed ID: 34298128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Modification of the AAV5 Capsid with Lysine Residues Results in a Lung-Tropic Liver-Detargeted Gene Transfer Vector.
    Stiles KM; Frenk EZ; Kaminsky SM; Crystal RG
    Hum Gene Ther; 2022 Feb; 33(3-4):148-154. PubMed ID: 35018834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multiplexed barcode approach to simultaneously evaluate gene delivery by adeno-associated virus capsid variants in nonhuman primates.
    Stone D; Meumann N; Kuhlmann AS; Peterson CW; Xie H; Roychoudhury P; Loprieno MA; Vu XK; Strongin DE; Kenkel EJ; Haick A; Stensland L; Obenza WM; Parrott J; Nelson V; Murnane RD; Huang ML; Aubert M; Kiem HP; Büning H; Jerome KR
    Hepatol Commun; 2023 Feb; 7(2):e0009. PubMed ID: 37074875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and biodistribution of under-employed gene therapy vector AAV7.
    Yost SA; Firlar E; Glenn JD; Carroll HB; Foltz S; Giles AR; Egley JM; Firnberg E; Cho S; Nguyen T; Henry WM; Janczura KJ; Bruder J; Liu Y; Danos O; Karumuthil-Melethil S; Pannem S; Yost V; Engelson Y; Kaelber JT; Dimant H; Smith JB; Mercer AC
    J Virol; 2023 Nov; 97(11):e0116323. PubMed ID: 37843374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodistribution of Adeno-Associated Virus Gene Therapy Following Cerebrospinal Fluid-Directed Administration.
    Chen X; Lim DA; Lawlor MW; Dimmock D; Vite CH; Lester T; Tavakkoli F; Sadhu C; Prasad S; Gray SJ
    Hum Gene Ther; 2023 Feb; 34(3-4):94-111. PubMed ID: 36606687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates.
    Gray SJ; Nagabhushan Kalburgi S; McCown TJ; Jude Samulski R
    Gene Ther; 2013 Apr; 20(4):450-9. PubMed ID: 23303281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Intrathecal Routes of Administration for Adeno-Associated Viral Vectors in Large Animals.
    Hinderer C; Bell P; Katz N; Vite CH; Louboutin JP; Bote E; Yu H; Zhu Y; Casal ML; Bagel J; O'Donnell P; Wang P; Haskins ME; Goode T; Wilson JM
    Hum Gene Ther; 2018 Jan; 29(1):15-24. PubMed ID: 28806897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN.
    Hinderer C; Katz N; Buza EL; Dyer C; Goode T; Bell P; Richman LK; Wilson JM
    Hum Gene Ther; 2018 Mar; 29(3):285-298. PubMed ID: 29378426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice.
    Liguore WA; Domire JS; Button D; Wang Y; Dufour BD; Srinivasan S; McBride JL
    Mol Ther; 2019 Nov; 27(11):2018-2037. PubMed ID: 31420242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular Inflammatory Response to Intravitreal Injection of Adeno-Associated Virus Vector: Relative Contribution of Genome and Capsid.
    Timmers AM; Newmark JA; Turunen HT; Farivar T; Liu J; Song C; Ye GJ; Pennock S; Gaskin C; Knop DR; Shearman MS
    Hum Gene Ther; 2020 Jan; 31(1-2):80-89. PubMed ID: 31544533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Safety and Biodistribution of AAVrh.10hCLN2 Following Intracisternal Administration in Nonhuman Primates for the Treatment of CLN2 Batten Disease.
    De BP; Rosenberg JB; Selvan N; Wilson I; Yusufzai N; Greco A; Kaminsky SM; Heier LA; Ricart Arbona RJ; Miranda IC; Monette S; Nair A; Khanna R; Crystal RG; Sondhi D
    Hum Gene Ther; 2023 Sep; 34(17-18):905-916. PubMed ID: 37624739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Analysis of the Capsid Structures of AAVrh.10, AAVrh.39, and AAV8.
    Mietzsch M; Barnes C; Hull JA; Chipman P; Xie J; Bhattacharya N; Sousa D; McKenna R; Gao G; Agbandje-McKenna M
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31826994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term expression and safety of administration of AAVrh.10hCLN2 to the brain of rats and nonhuman primates for the treatment of late infantile neuronal ceroid lipofuscinosis.
    Sondhi D; Johnson L; Purpura K; Monette S; Souweidane MM; Kaplitt MG; Kosofsky B; Yohay K; Ballon D; Dyke J; Kaminksy SM; Hackett NR; Crystal RG
    Hum Gene Ther Methods; 2012 Oct; 23(5):324-35. PubMed ID: 23131032
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Hanlon KS; Cheng M; De La Cruz D; Patel N; Santoscoy MC; Gong Y; Ng C; Nguyen DM; Nammour J; Clark SW; Kozarsky K; Maguire CA
    bioRxiv; 2023 Sep; ():. PubMed ID: 37745398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of Dexamethasone Administration for Maintaining Global Transduction Efficacy of Adeno-Associated Virus Serotype 9.
    Chai Z; Zhang X; Dobbins AL; Rigsbee KM; Wang B; Samulski RJ; Li C
    Hum Gene Ther; 2019 Jul; 30(7):829-840. PubMed ID: 30700148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.